Keros Therapeutics Inc (KROS) institutional holders · rev $243.9M
Keros Therapeutics Inc 13F cache, top 2 holders by reported value. Each row is the filer's newest cached 13F for quarters ended 2026-06-30 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Filers whose newest cached 13F is older are omitted.
| Holder | Shares | Value | Report |
|---|---|---|---|
| STATE STREET CORP | 541,193 | $5.8M | 2026-06-30 |
| FMR LLC | 35,328 | $378.0K | 2026-06-30 |
KROS institutional holders FAQ
How many KROS 13F holders are listed on this page?
This page lists 2 cached Keros Therapeutics Inc (KROS) 13F holders. Holders: https://lician.com/institutional/kros
Who is the largest KROS 13F holder by reported value?
The largest cached 13F holder by reported value on this page is STATE STREET CORP. Filer: https://lician.com/institutional/kros/93751. Holders: https://lician.com/institutional/kros
What value and shares did the largest KROS 13F holder report?
STATE STREET CORP, the largest cached 13F holder by reported value on this page, reported 541,193 shares and a value of $5.8M.
What is the latest KROS 13F report date on this page?
The latest cached 13F report date on this Keros Therapeutics Inc (KROS) holders table is Jun 30, 2026.
Which KROS 13F holders report the largest positions?
The largest cached 13F holders by reported value on this Keros Therapeutics Inc (KROS) page are STATE STREET CORP and FMR LLC. Holders: https://lician.com/institutional/kros
Where are KROS institutional holders listed?
Cached 13F holders for Keros Therapeutics Inc (KROS) are listed at https://lician.com/institutional/kros. Filer directory: https://lician.com/holders
What is KROS's latest revenue?
Latest cached Keros Therapeutics Inc (KROS) revenue for Dec 31, 2025 was $243.9M. Statements: https://lician.com/financials/kros
Not investment advice. Cached rows, not a live tape.